ArticleAmerican journal of epidemiology2023
Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis.
Taito Kitano et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it